Dmitry Balyasny’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.16M Buy
+13,704
New +$2.16M ﹤0.01% 1834
2026
Q1
– Sell
-53,091
Closed -$6.63M – 3610
2025
Q4
$6.47M Sell
53,091
-50,384
-49% -$5.78M 0.01% 1262
2025
Q3
$10.4M Sell
103,475
-113,932
-52% -$10.3M 0.01% 1039
2025
Q2
$18M Sell
217,407
-60,598
-22% -$4.83M 0.03% 708
2025
Q1
$22.5M Buy
278,005
+81,631
+42% +$7.3M 0.04% 552
2024
Q4
$17.7M Buy
196,374
+91,538
+87% +$8.87M 0.03% 722
2024
Q3
$10.4M Sell
104,836
-139,104
-57% -$13.7M 0.02% 929
2024
Q2
$22.6M Buy
243,940
+85,112
+54% +$7.63M 0.04% 562
2024
Q1
$15.1M Sell
158,828
-14,010
-8% -$1.3M 0.03% 758
2023
Q4
$15.4M Sell
172,838
-10,011
-5% -$743K 0.03% 701
2023
Q3
$13.4M Buy
182,849
+176,260
+2,675% +$14.1M 0.03% 731
2023
Q2
$548K Sell
6,589
-44,949
-87% -$3.76M ﹤0.01% 1825
2023
Q1
$3.93M Buy
+51,538
New +$4.28M 0.01% 1176
2022
Q4
– Sell
-27,196
Closed -$2.2M – 3289
2022
Q3
$2.16M Sell
27,196
-67,102
-71% -$5.66M 0.01% 1453
2022
Q2
$7M Buy
94,298
+56,482
+149% +$4.24M 0.02% 800
2022
Q1
$3.4M Sell
37,816
-20,192
-35% -$1.86M 0.01% 1119
2021
Q4
$6.5M Buy
+58,008
New +$7M 0.02% 769
2019
Q4
– Sell
-750,000
Closed -$57.2M – 1539
2019
Q3
$57.2M Buy
+750,000
New +$62.3M 0.39% 47
2018
Q1
– Sell
-219,000
Closed -$18.6M – 2363
2017
Q4
$18.6M Buy
+219,000
New +$18.3M 0.06% 430
2015
Q3
– Sell
-33,000
Closed -$2.78M – 1409
2015
Q2
$2.78M Buy
+33,000
New +$2.57M 0.02% 703

Other funds holding XBI

Dmitry Balyasny's XBI Position: Q3 2026 in Review

Dmitry Balyasny opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 13,704 shares worth $2.16M. The stake represents ﹤0.01% of the portfolio and ranks #1834 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in XBI as recently as Q4 2025.

Dmitry Balyasny first reported a position in XBI in Q2 2015 and has held it in 20 quarters since. The position peaked at $57.2M in Q3 2019. 962 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Dmitry Balyasny held 13,704 shares of State Street SPDR S&P Biotech ETF worth $2.16M as of Q3 2026.
  • State Street SPDR S&P Biotech ETF was a new Dmitry Balyasny position in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Dmitry Balyasny's portfolio in Q3 2026, its #1834 holding.
  • Dmitry Balyasny first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and has held it in 20 quarters since.
  • Dmitry Balyasny's State Street SPDR S&P Biotech ETF position peaked at $57.2M in Q3 2019.
  • 962 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.